USPH
U.S. Physical Therapy, Inc.
NYSE · Healthcare · Medical - Care Facilities · US
$79.35
+0.90%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 779.1M | 781.0M | 671.3M | 604.8M | 553.1M |
| Cost of Revenue | 629.7M | 623.6M | 547.4M | 483.3M | 441.1M |
| Gross Profit | 149.4M | 157.3M | 123.9M | 121.5M | 112.0M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 13.7M | — | 58.3M | — | 46.1M |
| General & Admin Expense | — | — | 58.3M | — | 46.1M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 51.4M | 76.9M | 2.4M | 69.4M | 9.1M |
| Total Operating Expenses | 65.1M | 76.9M | 60.7M | 69.4M | 55.2M |
| Cost and Expenses | 694.9M | 700.6M | 608.1M | 552.7M | 496.3M |
| Operating Income (EBIT) | 84.2M | 80.4M | 63.2M | 52.1M | 56.8M |
| Non-Operating | |||||
| Interest Income | 98.0K | 105.0K | 3.9M | 3.8M | — |
| Interest Expense | 10.8M | 9.5M | 8.0M | 9.3M | 5.8M |
| Net Interest Income | (10.7M) | (9.4M) | (4.1M) | (5.5M) | (5.8M) |
| Other Non-Op Income/Expense | (16.8M) | (2.6M) | (3.0M) | (2.7M) | (1.2M) |
| Non-Operating Income (excl Interest) | 6.0M | (6.8M) | (5.0M) | (6.6M) | (4.5M) |
| EBT (Pre-Tax Income) | 67.4M | 77.8M | 60.2M | 49.4M | 55.6M |
| Income Tax Expense | 17.6M | 19.8M | 14.6M | 12.2M | 12.2M |
| Bottom Line | |||||
| Net Income | (6.0M) | 15.1M | 26.5M | 14.7M | 28.3M |
| Earnings from Cont. Ops | 49.9M | 58.0M | 45.6M | 37.2M | 43.4M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 2.6M | 21.6M | 27.7M | 18.1M | 29.3M |
| Per Share | |||||
| Basic EPS | $0.17 | $1.42 | $1.84 | $1.28 | $3.34 |
| Diluted EPS | $0.17 | $1.42 | $1.84 | $1.28 | $3.34 |
| Revenue Per Share | $51.70 | $51.47 | $44.57 | $42.63 | $42.60 |
| Shares | |||||
| Basic Shares Outstanding | 15.1M | 15.2M | 15.1M | 14.2M | 13.0M |
| Diluted Shares Outstanding | 15.1M | 15.2M | 15.1M | 14.2M | 13.0M |
| Profitability Metrics | |||||
| EBITDA | 100.3M | 109.7M | 86.9M | 74.4M | 76.1M |
| D&A | 22.1M | 22.4M | 18.7M | 15.7M | 14.7M |
| EBIT | 78.2M | 87.3M | 68.2M | 58.7M | 61.4M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026